RGEN — REPLIGEN CORP

Ownership history in Man Group plc · 21 quarters on record

This page tracks every 13F SEC filing in which Man Group plc reported a position in REPLIGEN CORP (RGEN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.04% (2021 Q4)

Avg. % of fund

0.02%

First filed

2019 Q1

Last filed

2025 Q3

Quarters held

21

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	ADDED	76,187	+74,370	+4093.0%	0.02%	$10.2M	$133.67
2025 Q2	REDUCED	1,817	-45,584	-96.2%	0.00%	$226K	$124.38
2025 Q1	REDUCED	47,401	-48,248	-50.4%	0.02%	$6.0M	$127.24
2024 Q4	ADDED	95,649	+41,770	+77.5%	0.04%	$13.8M	$143.94

% of Fund (quarterly) RGEN price (monthly, adj. close)

Other funds also holding RGEN

As of 2025 Q4 — sorted by position size

Iron Triangle Partners LP 3Y 6.0% 12 West Capital Management LP 3Y 7Y 4.71% BROWN CAPITAL MANAGEMENT LLC 3Y 7Y 3.68% Conestoga Capital Advisors, LLC 3Y 7Y 2.92% UNITED CAPITAL FINANCIAL ADVISORS, LLC 3Y 7Y 2.73% Blue Whale Capital LLP 3Y 2.59% AMERICAN CAPITAL MANAGEMENT INC 3Y 7Y 2.42% Avidity Partners Management LP 3Y 2.38% Ranger Investment Management, L.P. 3Y 7Y 1.83% RTW INVESTMENTS, LP 3Y 7Y 1.75%

← Back to Man Group plc Holdings